Literature DB >> 12586669

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.

Mary E Ramsay1, Nick J Andrews, Caroline L Trotter, Edward B Kaczmarski, Elizabeth Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12586669      PMCID： PMC148893          DOI： 10.1136/bmj.326.7385.365

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England.

Authors:  M E Ramsay; N Andrews; E B Kaczmarski; E Miller
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

2.  Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

Authors:  Martin C J Maiden; James M Stuart
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

3.  Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign.

Authors:  C L Trotter; M E Ramsay; E B Kaczmarski
Journal:  Commun Dis Public Health       Date:  2002-09

4.  Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.

Authors:  E Miller; D Salisbury; M Ramsay
Journal:  Vaccine       Date:  2001-10-15       Impact factor: 3.641

5.  Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales.

Authors:  Caroline L Trotter; W John Edmunds
Journal:  BMJ       Date:  2002-04-06
  5 in total
  100 in total

1.  Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction.

Authors:  David A Ishola; Ray Borrow; Helen Findlow; Jamie Findlow; Caroline Trotter; Mary E Ramsay
Journal:  Clin Vaccine Immunol       Date:  2012-05-30

Review 2.  The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.

Authors:  Robert Welte; Caroline L Trotter; W John Edmunds; Maarten J Postma; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Conjugate vaccines.

Authors:  A Finn; P Heath
Journal:  Arch Dis Child       Date:  2005-07       Impact factor: 3.791

4.  A study of physico-chemical interactions between Haemophilus influenzae type b and meningococcus group C conjugate vaccines.

Authors:  Robert B D Otto; Dennis T Crane; Barbara Bolgiano
Journal:  Afr Health Sci       Date:  2007-12       Impact factor: 0.927

5.  Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.

Authors:  Martin C J Maiden; Ana Belén Ibarz-Pavón; Rachel Urwin; Stephen J Gray; Nicholas J Andrews; Stuart C Clarke; A Mark Walker; Meirion R Evans; J Simon Kroll; Keith R Neal; Dlawer A A Ala'aldeen; Derrick W Crook; Kathryn Cann; Sarah Harrison; Richard Cunningham; David Baxter; Edward Kaczmarski; Jenny Maclennan; J Claire Cameron; James M Stuart
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

6.  Seroprotection against serogroup C meningococcal disease.

Authors:  Lucieni O Conterno; Paul T Heath
Journal:  BMJ       Date:  2008-06-05

7.  Neisseria infection of rhesus macaques as a model to study colonization, transmission, persistence, and horizontal gene transfer.

Authors:  Nathan J Weyand; Anne M Wertheimer; Theodore R Hobbs; Jennifer L Sisko; Nyiawung A Taku; Lindsay D Gregston; Susan Clary; Dustin L Higashi; Nicolas Biais; Lewis M Brown; Shannon L Planer; Alfred W Legasse; Michael K Axthelm; Scott W Wong; Magdalene So
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals.

Authors:  Paul Balmer; Michelle Falconer; Paula McDonald; Nick Andrews; Emily Fuller; Christine Riley; Edward Kaczmarski; Raymond Borrow
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 9.  Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?

Authors:  Helen Findlow; Ray Borrow
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 10.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.